¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÆó°æÇÐȸ Á¦60Â÷ Ãß°èÇмú´ëȸ : 2023-11-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÆó°æÇÐȸ Á¦60Â÷ Ãß°èÇмú´ëȸ : 2023-11-19
±³À°ÀÏÀÚ : 2023-11-19
±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ¿È´Ï¹ö½ºÆÄÅ© LÃþ(B3) Ç÷»Æ¼ÄÁº¥¼Ç

±³À°ÁÖÁ¦ : Á¦60Â÷ Ãß°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑÆó°æÇÐȸ
´ã´çÀÚ : ±èº¸¿µ
¿¬¶ôó : 010-7151-1633  

À̸ÞÀÏ : ksm1992@empas.com

±³À°Á¾·ù : »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, °¡Á¤ÀÇÇаú, ¾à¸®ÇÐ, ÀÇÇб³À°, ±âŸ

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 90,000¿ø  

ºñ°í "ȸ¿ø : »çÀüµî·Ï 7¸¸¿ø , ÇöÀåµî·Ï 8¸¸¿ø

ºñȸ¿ø : »çÀüµî·Ï 8¸¸¿ø, ÇöÀåµî·Ï 9¸¸¿ø 

Àü°øÀÇ,°£È£»ç : »çÀüµî·Ï 4¸¸¿ø, ÇöÀåµî·Ï 5¸¸¿ø"  


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:00~09:10 (±¸¿¬¹ßÇ¥)A study comparing efficacy of transdermal MHT and oral MHT on bone health in women with functional hypothalamic amenorrhea ±è°æ¹Î(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:10~09:20 (±¸¿¬¹ßÇ¥)Investigation for relationship between menopausal vasomotor symptoms and hypothalamus volumetry using magnetic resonance imaging among Korean women Á¤³ª¿µ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:20~09:30 (±¸¿¬¹ßÇ¥)Successful removal of an old pessary with the total vagina obstruction ±èÁÖ¿¬(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:30~09:40 (±¸¿¬¹ßÇ¥)Hormone replacement therapy and Breast cancer incidence in Korean women. ½É¿¹ºó(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:40~09:50 (±¸¿¬¹ßÇ¥)Relationship between handgrip strength and metabolic syndrome in Korean postmenopausal women: the Korea National Health and Nutrition Examination Survey ÀÌÀºÁø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 09:50~10:00 (±¸¿¬¹ßÇ¥)A study of digital therapeutics for menopausal women with sarcopenia Á¤¿¬¼ö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:00~10:10 (±¸¿¬¹ßÇ¥)The association between tamoxifen use and menopause-related symptoms among women with breast cancer ÃÖº°ÀÌ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:10~10:20 (±¸¿¬¹ßÇ¥)Æó°æ±â È£¸£¸ó Ä¡·áÁ¦¿Í ¾ÏÀÇ ¿¬°ü¼º: Çѱ¹ÀÇ Àü±¹ÀûÀÎ ÈÄÇâÀû ÄÚȣƮ ¿¬±¸ À°Áø¼º(ÀÎÁ¦ÀÇ´ë)

ÈÞ½Ä 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:20~10:40 Coffee Break ( )

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 10:40~11:10 menopause Management : Update for 2023 Jan L. Shifren(ÇØ¿Ü¿¬ÀÚ)

Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 11:10~11:20 Q&A ( )

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 11:20~11:40 ´º·ÎÅ°´Ñ ¼ö¿ëü ÀÛ¿ë±âÀü°ú Fezolinentant, Elizanetant ¿¬±¸ °á°ú Á¤¸® ¹ÚÇöÅÂ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 11:40~12:00 Genitourinary syndrome of menopauseÀÇ ¾à¹° Ä¡·á ¹Ú¼Ò¿¬(ÀÌÈ­ÀÇ´ë)

Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 12:00~12:10 Q&A ( )

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 12:10~12:30 Treatment journey to protect bones from fractures ³²±ÃÁ¤(°¡Å縯ÀÇ´ë)

½Ä»ç 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 12:30~13:30 Lunch ( )

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 13:30~13:50 °ñ°¨¼ÒÁõ ¾î¶»°Ô Ä¡·áÇÒ±î ±èÀ¯Áø(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 13:50~14:10 °ñ´Ù°øÁõÀÇ Ä¡·á ÈÄ °ñ¹Ðµµ°¡ Áõ°¡µÈ °æ¿ì ¾à¹°Ä¡·á ¼±Åà Àü¼º¿í(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 14:10~14:20 Q&A ( )

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 14:20~14:50 The impacts of MHT on longer-term health consequences of ovarian hormone deficiency À±º´±¸(Re2 Climic)

ÈÞ½Ä 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 14:50~15:10 Coffee Break ³²±ÃÁ¤(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 15:10~15:30 Æó°æ ¿¹ÃøÀ» À§ÇÑ °Ë»ç¹ý ¾÷µ¥ÀÌÆ® Ȳ±Ô¸®(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 15:30~15:50 COVID ¹é½Å:¿ù°æ ÀÌ»ó ¹× ³­¼Ò ±â´É¿¡ ´ëÇÑ ¿µÇâÀº Á¶½ÃÇö(¿¬¼¼ÀÇ´ë)

Åä·Ð 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 15:50~16:00 Q&A ( )

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 16:00~16:20 È£¸£¸ó Ä¡·á¿Í Ä¡¸Å Á¤À±Áö(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 11¿ù 19ÀÏ Ç÷»Æ¼ÄÁº¥¼Ç 16:20~16:40 À¯¹æ¾Ï ȯÀÚ¿¡¼­ Æó°æ Áõ»ó °ü¸®ÀÇ ¾÷µ¥ÀÌÆ® Á¶¹®°æ(Àü³²ÀÇ´ë)

Åä·Ð 11¿ù 19ÀÏ 16:40~16:50 Q&A ( )

±âŸ 11¿ù 19ÀÏ 16:50~17:00 ½Ã»ó ( )

±âŸ 11¿ù 19ÀÏ 17:00~17:05 Æóȸ ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÆó°æÇÐȸ Á¦60Â÷ Ãß°èÇмú´ëȸ : 2023-11-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â °³¿øÀÇ ¹× Àü°øÀǸ¦ À§ÇÑ ¹éº´¿ø(ºÎ»ê/ÇØ¿î´ë) ½ÉÀå³»°ú ¿¬¼ö°­Á : 2023-11-19
´ÙÀ½±Û ´ëÇÑ°ñÀýÇÐȸ Á¦14ȸ ¿¬¼ö°­Á : 2023-11-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 3 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 3 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 107 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 9 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 23 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 10 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 5 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 4 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 6 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 9 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷